12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several healthcare stocks experienced significant movements. NGM Biopharmaceuticals, Cue Health, Homology Medicines, Cue Biopharma, Cadrenal Therapeutics, and Biophytis saw their shares rise, with NGM leading the gainers. Conversely, Corcept Therapeutics, China SXT Pharmaceuticals, LumiraDx, Aditxt, Fresh2 Group, and Qilian Intl Hldg Gr faced declines, with Corcept Therapeutics experiencing the largest drop.
January 01, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Corcept Therapeutics shares fell sharply by 38.4% to $20.0, with a market cap of $2.0 billion.
The significant drop in Corcept Therapeutics' share price could indicate negative news or market sentiment, likely leading to a bearish short-term outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
China SXT Pharmaceuticals stock declined by 31.49% to $2.72, with a market cap of $1.5 million.
The sharp decline in China SXT Pharmaceuticals' stock price suggests negative investor sentiment, which could persist in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Cue Health shares increased by 35.38% to $0.22, with a market cap of $34.0 million.
The substantial rise in Cue Health's stock price indicates a positive reaction from the market, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
NGM Biopharmaceuticals shares surged 43.2% to $1.23, with a market cap of $101.7 million.
The significant after-market gain for NGM Biopharmaceuticals suggests positive investor sentiment, which could lead to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100